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Abstract
Background: The phosphodiesterase 4D (PDE4D) gene was reported as a susceptibility gene to stroke. The genetic 
effect might be attributed to its role in modulating the atherogenic process in the carotid arteries. Using carotid intima-
media thickness (IMT) and plaque index as phenotypes, the present study sought to determine the influence of this 
gene on subclinical atherosclerosis.
Methods: Carotid ultrasonography was performed on 1013 stroke-free subjects who participated in the health 
screening programs (age 52.6 ± 12.2; 47.6% men). Genotype distribution was compared among the high-risk (plaque 
index ≥ 4), low-risk (index = 1-3), and reference (index = 0) groups. We analyzed continuous IMT data and further 
dichotomized IMT data using mean plus one standard deviation as the cutoff level. Because the plaque prevalence and 
IMT values displayed a notable difference between men and women, we carried out sex-specific analyses in addition to 
analyzing the overall data. Rs702553 at the PDE4D gene was selected because it conferred a risk for young stroke in our 
previous report. Previous young stroke data (190 cases and 211 controls) with an additional 532 control subjects 
without ultrasonic data were shown as a cross-validation for the genetic effect.
Results: In the overall analyses, the rare homozygote of rs702553 led to an OR of 3.1 (p = 0.034) for a plaque index ≥ 4. 
When subjects were stratified by sex, the genetic effect was only evident in men but not in women. Comparing male 
subjects with plaque index ≥ 4 and those with plaque index = 0, the TT genotype was over-represented (27.6% vs. 
13.4%, p = 0.008). For dichotomized IMT data in men, the TT genotype had an OR of 2.1 (p = 0.032) for a thicker IMT at 
the common carotid artery compared with the (AA + AT) genotypes. In women, neither IMT nor plaque index was 
associated with rs702553. Similarly, SNP rs702553 was only significant in young stroke men (OR = 1.8, p = 0.025) but not 
in women (p = 0.27).
Conclusions: The present study demonstrates a sex-differential effect of PDE4D on IMT, plaque index and stroke, 
which highlights its influence on various aspects of atherogenesis.
Background
Stroke is a heterogeneous multifactorial disorder, to
which both the environmental and genetic factors con-
tribute [1,2]. The phosphodiesterase 4D (PDE4D) gene
was identified as a stroke susceptibility [3]. Several stud-
ies tried to replicate this association in different popula-
tions but the results were conflicting [4-18]. The complex
entity and heterogeneity of stroke might be responsible
for the inconsistent findings among studies. Given that
atherosclerosis proceeds long before the occurrence of
clinical ischemic event, using the severity of carotid ath-
erosclerosis as a phenotype may reduce the complexity
and improve the power to detect the PDE4D genetic
effect.
Carotid intima-media thickness (IMT) and plaques
have been shown to be good independent predictors for
future vascular events [19,20]. Despite the fact that both
phenotypes correlate well to the pathologically and clini-
cally defined atherosclerosis, they represent distinct traits
with unique determinants and relationships to athero-
sclerosis [21]. IMT is akin to a physical effect adapting to
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aging and hypertensive stress whereas plaque corre-
sponds to a more pathogenic alternation in the vessel
walls [22]. Therefore, these two phenotypes can be used
as independent surrogate markers in the genetic studies
of atherosclerosis.
Sex-specific relationships between IMT and the envi-
ronmental factors like triglyceride, smoking and physical
activities have been demonstrated in the Tromsφ study
[23]. In addition, the association between inflammatory
markers and IMT progression is stronger in women than
in men [24]. The lower incidence of cardiovascular dis-
ease in premenopausal women [25] suggests a different
susceptibility to atherosclerosis in men and women.
Accordingly, the genetic effect on IMT or plaque may be
modified by sex.
Among the literature investigating the associations
between the PDE4D gene and stroke, only one study
included IMT and plaque as phenotypes of interest [26].
This study only enrolled participants between ages 50
and 65; thus their results may not generalize to the popu-
lation at large. In the present study, we sought to deter-
mine whether the PDE4D gene is involved in the pre-
clinical atherogenic process, ranging from the early
changes in the vessel morphology (i.e. IMT) to a later
stage of atherosclerosis (i.e. plaque formation). The SNP
rs702553 at the PDE4D gene (i.e. SNP56 from the original
study by Gretarsdottir et al.[3]) was selected because it
conferred a risk to young ischemic stroke in our previous
study [27]. To clarify the influence of sex on the relation-
ship between the PDE4D gene and carotid atherosclero-
sis, we first performed the analyses in the overall data and
then analyzed the data from men and women separately.
Methods
Subjects
The study subjects were stroke- and myocardial infarc-
tion (MI)-free volunteers who participated in the health
screening programs at the Kaohsiung Medical University
Hospital between January 2006 and December 2007. A
total of 1013 subjects were enrolled for carotid ultra-
sonography examinations. To compare the genetic effect
across the atherosclerotic phenotypes, we also used the
previous young stroke data (including 190 cases and 211
age-matched controls) [27] with an additional 532 control
subjects who were younger than 45 years old. These
young subjects were recruited from the Kaohsiung Medi-
cal University and did not receive carotid ultrasound
examinations. All of the study participants were descen-
dants of Han Chinese resided at southern Taiwan.
Demographic data and histories of hypertension, diabe-
tes mellitus, and cigarette smoking were obtained from
each study subject. Blood pressure measurements were
done using a calibrated standard aneroid sphygmoma-
nometer (Omron; Vernon Hills, Illinois) after sitting for
at least 5 minutes and the average values from two mea-
surements were used. A subject was defined as having
hypertension if he had systolic blood pressure ≥140 mm
Hg or diastolic pressure ≥90 mm Hg, or was taking anti-
hypertensive medications. A subject was defined as hav-
ing diabetes if he had fasting blood glucose ≥126 mg/dl or
was taking hypoglycemic medications. A subject was
defined as having hyperlipidemia if he had serum levels of
total cholesterol (TC) ≥ 240 mg/dl. Overnight fasting
venous blood was collected for biochemistry analyses and
genetic studies. Serum levels of TC were determined
using standardized enzymatic procedures (Boehringer
Mannheim, Germany). A subject was defined as a smoker
if he ever smoked (including current or past smoker). All
study protocols and methods were approved by the local
Institutional Review Board (IRB).
Carotid ultrasonography studies
The ultrasonic examinations were assessed using the
Philips HD 11 ultrasonography system equipped with a
7.5 Hz to 10 Hz linear array transducer (Philips Medical
Systems, Bothell, Washington, US). An experienced tech-
nician who was blinded to the patients' clinical data per-
formed all the ultrasonic measurements. Subjects were
examined in supine position. The transducer scanning
direction was using anterior-oblique insonation. The far
walls of carotid IMT were visualized bilaterally and the
IMT values were measured at the plaque-free area of the
common carotid artery (CCA, 10 to 20 mm proximal to
the tip of the flow divider), carotid bifurcation (Bif, tip of
the flow divider and extending 10 mm proximally) and
internal carotid artery (ICA, proximal 10 mm above the
bulb) separately. We used an automated computerized
analyzing system (Philips Qlab quantification software)
to improve the measurement accuracy. This new comput-
erized technique automatically detected the echo inter-
faces [28] and manual corrections were performed when
there was no automatic outlining of the lumen-intima or
the media-adventia interfaces. All the ultrasonic data
were interpreted by a single neurologist (HF Lin). The
mean absolute difference and standard deviation (SD)
between two measurements was 0.05 ± 0.04 mm.
Carotid plaque, defined as an area of focal protrusion
into the lumen at least 50% greater than the surrounding
wall thickness, was measured in 682 out of the 1013 par-
ticipants. The degree of plaque was graded using the fol-
lowing criteria [29]: grade 0, no observable plaque; grade
1, one small plaque (<30% of the vessel diameter); grade 2,
one medium plaque (30-50% of the vessel diameter) or
multiple small plaques; grade 3, one large plaque (>50% of
the vessel diameter) or multiple plaques with a least one
medium plaque. The plaque index was calculated by the
summation of plaque grades from five segments of the
carotid arteries bilaterally (proximal and distal CCA, Bif,Liao et al. BMC Medical Genetics 2010, 11:93
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ICA and extra-cranial carotid artery), which was a modi-
fied method based on the Sutton-Tyrrell's study [29].
Genotyping
Genomic DNA was isolated from the whole blood using
Puregene kit according to the manufacturer's protocols
(Gentra, Research Triangle, NC). Previously, we screened
four single nucleotide polymorphisms (SNPs) that were
implicated to be associated with stroke in the literature.
The four SNPs were rs12188950 (SNP45), rs702553
(SNP56), rs966221 (SNP83), and rs2910829 (SNP87). We
found that the SNP rs702553 was significantly associated
with young ischemic stroke in the Taiwanese population
[27]. In the present study, we further tested whether this
SNP was also related to other atherosclerotic phenotypes.
Genotyping was performed by the Applied Biosystems
TaqMan technology. Briefly, PCR primers and two allelic-
specific probes were designed to detect the specific SNP
target. The PCR reactions were performed in the 96-well
microplates with an ABI 7500 real-time PCR machine
(Applied Biosystems, Foster City, USA). Allele discrimi-
nation was achieved by detecting fluorescence using its
System SDS software version 1.2.3. The genotype calling
rate was 97.1%.
Statistical analysis
Genotype distribution was tested for Hardy-Weinberg
equilibrium (HWE) using the Goodness-of-fit test. Two
phenotypes (IMT and plaque index) were used as proxies
for carotid atherosclerosis. For carotid plaque, those with
a plaque index ≥ four were defined as high-risk individu-
als, subjects with an index between one and three were
defined as low-risk individuals, and those without any
observable plaque (index = 0) were defined as reference
individuals. Conditional logistic regression and the chi-
squared test were used to evaluate the difference in geno-
type distribution.
We analyzed both the continuous IMT data as well as
the dichotomized IMT data. For the dichotomized IMT
data, subjects with IMT values above the sex-specific and
age-adjusted mean plus one SD were defined as high-risk
individuals, and the rest of study subjects were defined as
reference individuals. Logistic regression with adjust-
ment for other cardiovascular risk factors (diabetes,
hypertension, hyperlipidemia and smoking) were used to
estimate the odds ratio (OR) and 95% confidence interval
(CI) for the risk genotype. For the continuous IMT data,
age-adjusted IMT values were log-transformed to
approximate the normal distribution. ANOVA and Stu-
dent's t-test were then used to compare the mean IMT
values across different genotypes.
We analyzed the genetic effect on the overall data as
well as the sex- specific genetic effect by stratifying the
subjects into men and women. The sex-genotype interac-
tion was further evaluated by (1) adding an interaction
term into the regression model, and (2) comparing the
difference of odds ratios in men and women using
Woolf's logit method and Z-test [30]. Since we tested the
PDE4D effect on seven phenotypes (i.e. plaque index,
dichotomized IMT data at three segments, continuous
IMT values at three segments) and performed the overall
and sex-stratification analyses (i.e. a total of 21 tests in
Table three), Tukey's ad hoc correction was adopted for
multiple testing correction [31]. To evaluate the genetic
effect on stroke, logistic regression was used to estimate
the OR for each genotype. We also performed subgroup
analyses stratified by sex. All statistical analyses were per-
formed with SPSS statistical software (version 13.0).
Results
The demographic features of the study population are
shown in Table 1. The genotype distribution was in
HWE. The minor allele frequency of rs702553 in the
present study was 0.41, which was quite close to those
reported in the three independent Japanese populations
(0.42-0.46) [6].
Among the 1013 subjects with IMT data, men had sig-
nificantly higher IMT values than women at any of the
three carotid segments (p = 7.7 × 10-9 - 1.8 × 10-16; Table
2). The average age-adjusted IMT values (mm) in men
and women were 0.64 vs. 0.59 at CCA, 0.67 vs. 0.63 at Bif,
and 0.54 vs. 0.48 at ICA. The cutoff levels (mm) to define
the high-risk and low-risk groups at CCA, Bif and ICA
were 0.77, 0.80 and 0.64 respectively in men; and 0.69,
0.73, and 0.57 respectively in women. Among the total
study participants, data on plaque index was available for
682 subjects. Up to 10.8% of the male subjects had a
plaque index ≥ four; whereas 1.7% of the female subjects
had a plaque index ≥ four (p = 1 × 10-7, Table 2). There
was a moderate association between the plaque index and
the age-adjusted IMT value from each carotid segment
(Pearson's correlation coefficient (r) = 0.24-0.35, p <
0.001).
The prevalence of the cardiovascular risk factors
(hypertension, diabetes, and smoking) was much higher
in men than in women (all p values < 0.05, Table 2). Sex
remained as an independent determinant of IMT values
in the multivariate regression no matter which carotid
segment was analyzed (p = 0.001 - 5.5 × 10-12).
Three genetic models (assuming the rare allele having a
dominant, recessive, or additive effect) were used to eval-
uate the associations between rs702553 and the athero-
sclerotic phenotypes. The rare allele appeared to exert a
recessive effect and the TT genotype was associated with
increased IMT values and a higher plaque index (Table 3).
Using individuals with no plaque as the reference group,
the TT genotype was over-represented in individuals
with a plaque index ≥ four (OR = 3.1, nominal p = 0.034,Liao et al. BMC Medical Genetics 2010, 11:93
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corrected p = 0.15). Actually, the TT genotype was only
significantly related to the high plaque index (plaque
index ≥ four) in men (OR = 5.9, nominal p = 0.008, cor-
rected p = 0.036) but not in women. There was no signifi-
cant association between the SNP rs702553 and the low-
risk group (plaque index = 1-3).
In the overall population, SNP rs702553 was not signif-
icant for IMT at any carotid segment. For the dichoto-
mized IMT data in men, the TT genotype had an OR of
2.1 (nominal p = 0.032) for a thicker CCA IMT in com-
parison to the A allele carriers. However, the p value was
not significant after Tukey's ad hoc correction (corrected
p = 0.14). The T allele was associated with an increased
IMT at Bif (p = 0.078) or ICA (p = 0.588) in men,
although the association was not statistically significant.
Table 1: Demographic characteristics of study subjects
Young stroke study IMT study
case (N = 190) control (N = 743) overall (N = 1013)
Age(yr) 38.1 ± 6.7 (15-45) † 26.0 ± 8.1 (16-45) 52.6 ± 12.2 (17-87)
Male 124(65.3%)† 336(45.2%) 482(47.6%)
Diabetes 65(34.2%) † 8(1.1%) 103(10.2%)
Hypertension 76(42.5%)† 45(6.1%) 318(31.4%)
Hyperlipidemia 18(10.8%)† 22(3.1%) 53(5.4%)
Smoker (current + past vs. never) 89(48.1%)† 60(8.1%) 208(20.7%)
Total cholesterol (mmol/L) 4.77 ± 1.30† 4.36 ± 0.89 4.83 ± 0.87
PDE4D rs702553
AA 60(32.6%) 278(37.9%) 352(36.3%)
AT 80(43.5%) 339(46.2%) 451(46.4%)
TT 44(23.9%) * 117(15.9%) 168(17.3%)
* p < 0.05, † p < 0.001 compared with controls of young stroke study.
Quantitative data are presented as mean ± SD
Table 2: Sex-differential distribution among carotid IMT, plaque index and cardiovascular risk factors (only subjects with 
ultrasonic data are presented)
Men (N = 482) Women (N = 531) p value*
Age(yr) 52.5 ± 12.2 52.8 ± 12.2 0.766
Diabetes 60(12.5%) 43(8.2%) 0.025
Hypertension 171(35.5%) 147(27.7%) 0.008
Hyperlipidemia 24(5.1%) 29(5.6%) 0.704
Smoking (current + past vs. never) 198(41.4%) 10(1.9%) 9.9 × 10-54
Total cholesterol (mmol/L) 4.79 ± 0.87 4.86 ± 0.87 0.180
Carotid plaque N = 268 N = 414
No plaque (index = 0) 159(59.3%) 288(69.6%) ref.
Low-risk group (index = 1 - 3) 80(29.9%) 119(28.7%) 0.260
High-risk group (index ≥ 4) 29(10.8%) 7(1.7%) 1 × 10-7
Age-adjusted carotid IMT (mm) N = 482 N = 531
CCA IMT 0.64 ± 0.13 0.59 ± 0.10 4.2 × 10-9
Bif IMT 0.67 ± 0.13 0.63 ± 0.10 7.7 × 10-9
ICA IMT 0.54 ± 0.11 0.48 ± 0.08 1.8 × 10-16
* Student's t-test or Chi-squared test.
Quantitative data are presented as mean ± SDL
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Table 3: The association between rs702553 at the PDE4D gene and carotid atherosclerosis
Atherosclerotic risk Overall Men Women
AA + AT TT statistics AA + AT TT statistics AA + AT TT statistics
Carotid plaque N = 544 N = 108 N = 216 N = 40 N = 328 N = 68
No plaque (index 
= 0)
354 (83.7%) 69 (16.3%) ref. 129 (86.6%) 20 (13.4%) ref. 225 (82.1%) 49 (17.9%) ref.
Low-risk (index = 
1-3)
163 (84.5%) 30 (15.5%) OR = 1.0 (0.6-1.7) p = 0.934 66 (84.6%) 12 (15.4%) OR = 1.5 (0.7-3.6) p = 0.312 97 (84.3%) 18 (15.7%) OR = 0.8 (0.4-1.5) P = 0.534
High-risk (index 
≥ 4)
27 (75.0%) 9 (25.0%) OR = 3.1 (1.1-8.7) p = 0.034 21 (72.4%) 8 (27.6%) OR = 5.9 (1.6-21.5) p = 0.008 6 (85.7%) 1 (14.3%) OR = NA
Age-adjusted 
IMT(mm)
N = 775 N = 162 N = 367 N = 76 N = 408 N = 86
CCA 0.61 ± 0.12 0.62 ± 0.11 p = 0.150 0.63 ± 0.14 0.66 ± 0.13 p = 0.041 0.59 ± 0.10 0.59 ± 0.08 p = 0.862
Bif 0.65 ± 0.12 0.66 ± 0.13 p = 0. 396 0.67 ± 0.12 0.70 ± 0.14 p = 0.068 0.63 ± 0.11 0.62 ± 0.09 p = 0.472
ICA 0.51 ± 0.10 0.51 ± 0.11 p = 0.518 0.53 ± 0.11 0.55 ± 0.13 p = 0.111 0.48 ± 0.08 0.48 ± 0.08 p = 0.441
Dichotomized IMT (advanced atherosclerotic group(> mean + 1SD)
CCA 98 (12.7%) 23 (14.5%), OR = 1.2 (0.7-1.9) p = 0.584 43 (11.7%) 17(22.4%) OR = 2.1 (1.1-4.1) p = 0.032 55 (13.5%) 6 (7.2%) OR = 0.5 (0.2-1.2) p = 0.109
Bif 110 (14.2%) 30 (18.9%), OR = 1.5 (0.9-2.3) p = 0.099 53 (14.5%) 17 (22.4%) OR = 1.8 (0.9-3.3) p = 0.078 57 (14.0%) 13 (15.7%) OR = 1.1 (0.6-2.2) p = 0.686
ICA 96 (12.5%) 20 (12.7%), OR = 1.0 (0.6-1.7) p = 0.940 36 (9.9%) 7 (9.2%) OR = 0.8 (0.3-1.9) p = 0.588 60 (14.8%) 13 (16.0%) OR = 1.1 (0.6-2.2) p = 0.724
OR (95% confidence interval) was obtained from logistic regression with adjustment of age, hypertension, diabetes, hyperlipidemia and smoking.
Age-adjusted IMT was presented as mean ± SDLiao et al. BMC Medical Genetics 2010, 11:93
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For women, the data was not significant for IMT at any
carotid segment.
We first used regression analysis to evaluate the sex-dif-
ferential effect of the PDE4D gene. For CCA IMT, the
existence of sex-genotype interaction was supported by a
p value of 0.009 for the interaction term in the regression
model. There was a borderline significance for the sex-
genotype interaction (p = 0.062) when plaque index was
the phenotype of interest. We further compared the odds
ratios in men and women between SNP rs702553 and the
various phenotypes (Figure 1). For CCA IMT, the TT
genotypes conferred a significantly higher odds ratio in
men than in women (OR (95% CI) = 2.16 (1.16-4.02) and
0.5 (0.21-1.16) respectively, p = 0.003). There was no sig-
nificant difference in the odds ratios for men and women
in other phenotypes.
The results from carotid atherosclerotic phenotypes
were in concordance with the results observed in our pre-
vious PDE4D young stroke study [27] where the TT geno-
type was over-represented in young stroke cases than in
the controls (23.9% vs. 15.9%, p = 0.01, Table 1). The TT
frequency in the control subjects resembled that in the
IMT study population who had no histories of stroke or
MI. Compared with the A allele carriers (AA + AT geno-
types), the TT genotype conferred an increased risk for
stroke in men (OR = 1.79, p = 0.025) but not in women
(OR = 1.44, p = 0.27) (Figure 2).
Discussion
The present study demonstrates a sex-differential effect
of the PDE4D gene on CCA IMT and plaque. The TT
genotype at SNP rs702553 is associated with an increased
risk not only for ischemic stroke but also for the preclini-
cal carotid atherosclerosis. The consistent genetic effect
on various atherosclerotic phenotypes suggests that one
of the major contributions of the PDE4D gene is to
increase atherosclerosis. Our results indicate that the
influence of the PDE4D gene begins long before the isch-
emic infarct, and its genetic effect on stroke is at least
partially attributed to the wall thickening and plaque for-
mation in the carotid arteries. In the present study, the
pro-atherogenic effect of PDE4D is mainly present in
men.
One of the strengths of the present study is using the
intermediate phenotypes as proxies of the more complex
clinical outcome (i.e. stroke). To our knowledge, there
was only one study investigating the PDE4D effect on
carotid atherosclerosis [26]. Bevan et al. found a border-
line significance for IMT but a negative result for plaque.
It should be noted that their study [26] used the arbitrary
cut off point of 1.8 mm of wall thickness to define the
presence or absence of plaque; whereas we used both the
size and the quantity of plaques to calculate the plaque
index.
We used both IMT and plaque index to estimate the
atherosclerosis severity because they measure different
aspects of atherogenesis [32]. IMT mainly represents
hypertensive hypertrophy of the vessel walls in response
to systemic hypertension and aging [22]. In contrast,
plaque probably reflects a later stage of atherosclerosis
when lipid infiltration, inflammation, matrix over-pro-
duction, endothelium dysfunction, and smooth muscle
cell proliferation take place [33]. Our results showed that
the PDE4D genetic effect is more prominent on plaque
index than CCA IMT. It implies that this gene plays a
more important role in the pathological process than the
physiological changes as IMT. In addition, the modest
correlation between plaque index and IMT supports that
these two phenotypes represent different aspects of ath-
erosclerotic process. In the present study, the genetic
effect of PDE4D is strongest in the CCA IMT, attenuated
in the Bif IMT, and completely disappeared in the ICA
Figure 1 Odds ratios for men and women between SNP rs702553 
and the various phenotypes. Mean log odds ratios along with the 
corresponding confidence intervals for men and women are shown. 
The p value under a Z distribution is used to test the difference of mean 
ln(OR) between men and women.
Figure 2 The association between SNP rs702553 and ischemic 
stroke in men and women. The numbers in the parentheses repre-
sent the sample size in controls and cases respectively.Liao et al. BMC Medical Genetics 2010, 11:93
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IMT. Genes with differential effects on different carotid
segments have been reported previously [34,35].
One intriguing finding in the present study is the
potential sex-differential effect of the PDE4D gene. This
sex-genotype interaction has not been reported in the
PDE4D gene. However, sex-specific effect has been dem-
onstrated in other genes [36,37]. For examples, the
endothelial NO synthase gene (NOS3) affects vascular
stiffness in women but not in men [36]. The solute carrier
family 2 member 9 (SLC2A9) gene accounts for a larger
proportion of uric acid variation in women than in men
[37]. Notably, 37.7% of our female subjects were below
the age of 50 years. They were still under the anti-athero-
sclerotic protection of estrogen [38,39], which might also
partially explain the lack of PDE4D genetic effect on the
female subjects. Joakimsen et al. reported a low plaque
prevalence in women younger than fifties and a linear
escalation from 10% to 80% at their 4th to 7th decades [39].
Indeed, the fact that only 7 female subjects were in the
high-risk group (plaque index ≥ 4) indicates that these
women might be too healthy to reveal the PDE4D genetic
effect. The small sample size in the high-risk group also
explains why a borderline significance was found for the
sex-genotype interaction in plaque.
Despite recent studies in the Han Chinese and Korean
showed significant associations between the PDE4D gene
and certain stroke subtypes [4,40,41], the largest PDE4D
association study conducted in the Asian population
(including 2847 stroke cases and 4464 controls in Japan)
showed a negative result [6]. The main finding of the
present study is to demonstrate the PDE4D effect on pre-
clinical carotid atherosclerosis. Therefore, their findings
in ischemic stroke may not be comparable to our results
in IMT and plaque index.
We selected rs702553 at the PDE4D gene as the candi-
date locus based on our previous findings in the young
stroke study [27]. This 5' SNP is located in a block that
has been associated with a reduced expression of the
PDE4D7 isoform in stroke patients [3]. In addition, differ-
ential expressions of the PDE4D isoforms have been
found during the transformation process of vascular
smooth muscle cells [42] and monocytes [43]. These
studies give a plausible explanation why the intronic SNP
rs702553 may modulate IMT progression and plaque for-
mation.
There are several limitations in the present study. First,
we only genotyped one SNP at the PDE4D gene and it
may not be sufficient to stand for the overall PDE4D
genetic effect. Second, the present findings should be
interpreted with caution because of the small sample size
in subgroup analyses. Yet, the current sample size had a
statistical power of 0.51-0.95 to detect a genetic effect of
odds ratio 2 with disease prevalence ranged from 10% to
30% and an alpha level of 0.011 http://pngu.mgh.har-
vard.edu/~purcell/gpc/[44]. Furthermore, we acknowl-
edged that a significant threshold of nominal p less than
0.05 might lead to false positive results when several phe-
notypes were tested concurrently. We presented both the
nominal p values and the Tukey's ad hoc corrected p val-
ues. The significance threshold represented a trade-off
between avoidance of false positive associations while
taking into account that a set of related phenotypes were
tested in the present study. We analyzed both continuous
and dichotomized IMT data because a certain threshold
may be needed in order to detect the atherogenic effect
[45]. There was no consensus on the definition of abnor-
mal IMT values and diverse cutoff points were used in
different studies [20,46]. We selected mean plus one SD
as the cutoff level to dichotomize thick and thin IMT to
be comparable to a previous study which used per SD dif-
ference in IMT values to estimate the atherosclerotic
risks [19]. We also divided the plaque index into three
risk groups (index = 0, 1-3, ≥ 4) rather than treating it as a
continuous variable for two reasons: (1) plaque index is
not normally distributed and the majority of our study
subjects (>60%) had no plaque, and (2) the size of plaque
could be ambiguous under different insonation angles.
Conclusions
The present study demonstrates that the rs702553 at the
PDE4D gene affects both the IMT progression and
plaque formation in the carotid arteries. Men have
thicker IMT values, a worse plaque profile, and a higher
prevalence of cardiovascular risk factors. Sex may modify
the relationships between the PDE4D genes and preclini-
cal atherosclerotic phenotypes. The lack of genetic effect
in women warrants further investigation and replication.
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